Tandem Diabetes Care Inc (NASDAQ: TNDM) is -39.89% lower on its value in year-to-date trading and has touched a low of $15.75 and a high of $53.69 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNDM stock was last observed hovering at around $23.52 in the last trading session, with the day’s loss setting it -1.87%.
Currently trading at $21.65, the stock is 2.61% and 11.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.35 million and changing -7.95% at the moment leaves the stock -31.57% off its SMA200. TNDM registered -54.23% loss for a year compared to 6-month loss of -20.81%. The firm has a 50-day simple moving average (SMA 50) of $19.4688 and a 200-day simple moving average (SMA200) of $31.638725.
The stock witnessed a 32.42% gain in the last 1 month and extending the period to 3 months gives it a -32.60%, and is -5.25% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.82% over the week and 5.40% over the month.
Tandem Diabetes Care Inc (TNDM) has around 2650 employees, a market worth around $1.44B and $982.95M in sales. Profit margin for the company is -18.71%. Distance from 52-week low is 37.45% and -59.68% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.32%).
The EPS is expected to grow by 6.85% this year
391.0 institutions hold shares in Tandem Diabetes Care Inc (TNDM), with institutional investors hold 112.24% of the company’s shares. The shares outstanding are 66.57M, and float is at 66.05M with Short Float at 10.42%. Institutions hold 111.30% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.12 million shares valued at $448.14 million. The investor’s holdings represent 17.1137 of the TNDM Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.38 million shares valued at $297.26 million to account for 11.3518 of the shares outstanding. The other top investors are CAPITAL WORLD INVESTORS which holds 3.67 million shares representing 5.6394 and valued at over $147.67 million, while UBS GROUP AG holds 4.2239 of the shares totaling 2.75 million with a market value of $110.61 million.
Tandem Diabetes Care Inc (TNDM) Insider Activity
The most recent transaction is an insider purchase by Kyrillos Jean-Claude, the company’s EVP & Chief Operating Officer. SEC filings show that Kyrillos Jean-Claude bought 10,538 shares of the company’s common stock on Mar 07 ’25 at a price of $18.12 per share for a total of $0.19 million. Following the purchase, the insider now owns 10538.0 shares.
Tandem Diabetes Care Inc disclosed in a document filed with the SEC on Nov 21 ’24 that BLICKENSTAFF KIM D (Director) sold a total of 30,000 shares of the company’s common stock. The trade occurred on Nov 21 ’24 and was made at $31.38 per share for $0.94 million. Following the transaction, the insider now directly holds 0.17 million shares of the TNDM stock.
Still, SEC filings show that on Nov 20 ’24, BLICKENSTAFF KIM D (Director) disposed off 10,000 shares at an average price of $30.00 for $0.3 million. The insider now directly holds 195,190 shares of Tandem Diabetes Care Inc (TNDM).
